QT
AMPH icon

Quantamental Technologies’s Amphastar Pharmaceuticals AMPH Stock Holding History

Quantamental Technologies’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,677
Closed -$267K – 492
2022
Q2 		$267K Buy
+7,677
New +$274K 0.12% 288
2019
Q4 		– Sell
-1,291
Closed -$26K – 461
2019
Q3 		$26K Sell
1,291
-696
-35% -$14.5K 0.01% 1148
2019
Q2 		$42K Sell
1,987
-925
-32% -$19.3K 0.02% 941
2019
Q1 		$59K Sell
2,912
-679
-19% -$15.2K 0.03% 804
2018
Q4 		$71K Buy
+3,591
New +$70.8K 0.04% 674

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Quantamental Technologies's AMPH Position: Q3 2022 in Review

Quantamental Technologies sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2022, closing a stake of 7,677 shares — an estimated $267K sold.

Quantamental Technologies first reported a position in AMPH in Q4 2018 and held it in 5 quarters. The position peaked at $267K in Q2 2022. 205 funds tracked by Wall St. Rank hold AMPH as of Q3 2022.

  • Quantamental Technologies reported no remaining Amphastar Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Quantamental Technologies sold 7,677 Amphastar Pharmaceuticals shares in Q3 2022, an estimated $267K.
  • Quantamental Technologies first reported a position in Amphastar Pharmaceuticals in Q4 2018 and held it in 5 quarters.
  • Quantamental Technologies's Amphastar Pharmaceuticals position peaked at $267K in Q2 2022.
  • 205 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.